Thomas Dowling
About Thomas Dowling
Thomas Dowling is the Senior Director at Bristol Myers Squibb in Summit, New Jersey, with extensive experience in analytical chemistry and regulatory affairs.
Company
Thomas Dowling is currently a Senior Director at Bristol Myers Squibb, a global biopharmaceutical company located in Summit, New Jersey, United States. Previously, he held multiple roles at Celgene, also based in Summit, New Jersey, including Senior Director and Director Regulatory/CMC.
Title
Thomas Dowling holds the position of Senior Director at Bristol Myers Squibb. His previous roles included Senior Director at Celgene and Senior Director Analytical Development at Merck. He possesses extensive experience in senior management positions, particularly in analytical development and regulatory affairs.
Education and Expertise
Thomas Dowling earned a PhD in Analytical Chemistry from the University of Massachusetts Amherst, where he studied from 1986 to 1991. He also holds a BS in Chemistry from the University of Connecticut, achieved between 1982 and 1986. His expertise spans over 15 years as an Analytical Chemist, with specialized knowledge in API process development and technology transfer. He is proficient in developing filing strategies and addressing global regulatory requirements.
Background
Thomas Dowling has over 15 years of experience supporting API process development and technology transfer to commercial production facilities. He managed a department of 35 analytical chemists, supporting process development for over 20 active small molecule drug candidates from Phase I through NDA filing and launch. His roles have required demonstrated project management and cross-functional team leadership skills.
Achievements
Throughout his career, Thomas Dowling has developed a strong portfolio in preparing global CMC submissions, with over 10 years of specialized experience. He has played key roles in multiple organizations, contributing significantly to their regulatory and analytical development programs. His work has ensured compliance with regulatory requirements in all key markets worldwide.